Medifast
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medifast generated cash of $147,657,000, which is less than the previous year. Cash used in financing activities reached the amount of -$79,789,000 last year. Net change in cash is therefore $6,749,000.
Cash Flow
| 2014 | 25.53M | -2.51M | -34.94M |
|---|---|---|---|
| 2015 | 29.41M | -189K | -11.73M |
| 2016 | 25.35M | -2.03M | -12.92M |
| 2017 | 43.23M | -3.16M | -17.36M |
| 2018 | 60.81M | -1.19M | -53.32M |
| 2019 | 84.26M | -6.32M | -82.32M |
| 2020 | 145.19M | -1.28M | -57.14M |
| 2021 | 94.54M | -29.06M | -125.13M |
| 2022 | 194.57M | -11.41M | -199.58M |
| 2023 | 147.65M | -61.04M | -79.78M |
MED Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.07M | 52.43M | 42.03M | 24.45M | 36.38M |
Operating activities | ||||||||||
Net income | 99.41M | 143.56M | 164.03M | 102.85M | 77.91M | 55.78M | 27.72M | 17.83M | 19.56M | 21.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 13.10M | 10.98M | 6.81M | 7.27M | 4.62M | 4.43M | 4.20M | 5.40M | 7.11M | 8.05M |
Stock-based compensation expense | 8.18M | 11.05M | 9.90M | 6.79M | 4.52M | 3.12M | 4.26M | 3.42M | 3.08M | 3.91M |
| Deferred income tax benefit | 8.18M | 11.05M | 9.90M | 6.79M | 4.52M | 3.12M | 4.26M | 3.42M | 3.08M | 3.91M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 37.59M | -54.38M | 297K | -4.06M | 122K | 815K | 246K | 17K | -708K |
Inventories | 64.26M | 61.18M | -126.65M | -4.62M | -9.88M | -18.65M | -1.01M | -4.97M | 2.4M | 1.80M |
Accounts payable | -35.70M | -37.59M | 54.38M | 25.73M | 10.61M | 15.79M | 8.00M | 197K | -2.12M | -1.04M |
Cash generated by operating activities | 147.65M | 194.57M | 94.54M | 145.19M | 84.26M | 60.81M | 43.23M | 25.35M | 29.41M | 25.53M |
Investing activities | ||||||||||
Purchases Of Investments | -54.56M | 0 | 0 | 0 | 0 | 0 | -6.95M | -26.57M | -9.25M | -26.08M |
Investments In Property Plant And Equipment | -6.48M | -16.68M | -34.20M | -5.88M | -10.05M | -4.94M | -3.24M | -2.87M | -2.81M | -7.02M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 196K | 81K | 676K | 0 | 0 |
Cash generated by investing activities | -61.04M | -11.41M | -29.06M | -1.28M | -6.32M | -1.19M | -3.16M | -2.03M | -189K | -2.51M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 811K | 1.59M | 0 | 547K | 0 | 299K | 0 | 0 |
Payments for dividends | -73.01M | -71.62M | -63.85M | -53.19M | -35.39M | -23.16M | -15.39M | -11.88M | 0 | 0 |
Repurchases of common stock | -6.96M | -127.96M | -62.08M | -5.55M | -47.20M | -30.71M | -2.54M | -1.34M | -11.81M | -35.04M |
Repayments of term debt | 0 | 0 | -811K | -1.59M | 0 | 0 | 0 | -219K | -255K | -222K |
Cash used in financing activities | -79.78M | -199.58M | -125.13M | -57.14M | -82.32M | -53.32M | -17.36M | -12.92M | -11.73M | -34.94M |
Net Change In Cash | 6.74M | -16.49M | -59.54M | 86.74M | -4.39M | 6.28M | 22.64M | 10.39M | 17.57M | -11.92M |
Cash at end of period | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.07M | 52.43M | 42.03M | 24.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |